Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Targeting allograft inflammatory factor 1 reprograms kidney macrophages to enhance repair
Irma Husain, … , Edward B. Thorp, Xunrong Luo
Irma Husain, … , Edward B. Thorp, Xunrong Luo
Published January 21, 2025
Citation Information: J Clin Invest. 2025;135(5):e185146. https://doi.org/10.1172/JCI185146.
View: Text | PDF
Research Article Immunology Nephrology Article has an altmetric score of 4

Targeting allograft inflammatory factor 1 reprograms kidney macrophages to enhance repair

  • Text
  • PDF
Abstract

The role of macrophages (MΦs) remains incompletely understood in kidney injury and repair. The plasticity of MΦs offers an opportunity to polarize them toward mediating injury resolution in both native and transplanted kidneys undergoing ischemia and/or rejection. Here, we show that infiltrating kidney MΦs augmented their own allograft inflammatory factor 1 (AIF-1) expression after injury. Aif1 genetic deletion led to MΦ polarization toward a reparative phenotype while halting the development of kidney fibrosis. The enhanced repair was mediated by higher levels of antiinflammatory and proregenerative markers, leading to a reduction in cell death and an increase in proliferation of kidney tubular epithelial cells after ischemia followed by reperfusion injury (I/RI). Adoptive transfer of Aif1–/– MΦs into Aif1+/+ mice conferred protection against I/RI. Conversely, depletion of MΦs reversed the tissue-reparative effects in Aif1–/– mice. We further demonstrated increased expression of AIF-1 in human kidney biopsies from native kidneys with acute kidney injury or chronic kidney disease, as well as in biopsies from kidney allografts undergoing acute or chronic rejection. We conclude that AIF-1 is a MΦ marker of renal inflammation, and its targeting uncouples MΦ reparative functions from profibrotic functions. Thus, therapies inhibiting AIF-1 when ischemic injury is inevitable have the potential to reduce the global burden of kidney disease.

Authors

Irma Husain, Holly Shah, Collin Z. Jordan, Naveen R. Natesh, Olivia K. Fay, Yanting Chen, Jamie R. Privratsky, Hiroki Kitai, Tomokazu Souma, Shyni Varghese, David N. Howell, Edward B. Thorp, Xunrong Luo

×

Figure 1

Kidney MΦs upregulate AIF-1 following kidney injury.

Options: View larger image (or click on image) Download as PowerPoint
Kidney MΦs upregulate AIF-1 following kidney injury.
(A–C) Single-cell s...
(A–C) Single-cell sequencing analysis of Aif1-expressing cells in murine allogeneic kidney transplantation. On day 15 after transplantation (BALB/c kidneys transplanted into bilateral nephrectomized B6 recipients), and naive, unmanipulated BALB/c kidneys were used as controls (n = 2 each). (A) Violin plot showing total Aif1 expression levels in naive and rejection kidneys. (B) Feature plots for naive and rejecting kidneys showing that myeloid cell subsets were the predominant cell populations expressing Aif1. (C) Violin plots showing Aif1 expression levels by cell type in both naive and rejection samples. PT, proximal tubule; T-lymph, T lymphocyte; Macro, MΦ; DCT, distal convoluted tubule; B-lymph, B lymphocyte; Macro/Mono, MΦ/monocyte; EC, endothelial cell; LOH, loop of Henle; CD, collecting duct; cDC, conventional DC; Neutro, neutrophil; pDC, plasmacytoid DC; Mast/Baso, mast cell/basophil. (D) Immunohistochemical staining for AIF-1 (brown) in naive kidneys and rejecting kidneys at day 15 after transplantation. Images are representative of 3 each. Original magnification, ×100 for stitch images; ×400 (insets). Scale bars: 500 μm and 20 μm, respectively.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 4 X users
Referenced by 1 Bluesky users
4 readers on Mendeley
See more details